Orgenesis Inc (ORGS)
0.5684
-0.01
(-2.07%)
USD |
NASDAQ |
Jun 26, 14:54
Orgenesis Free Cash Flow: -13.05M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -13.05M |
| December 31, 2023 | -16.93M |
| September 30, 2023 | -32.64M |
| June 30, 2023 | -38.73M |
| March 31, 2023 | -42.17M |
| December 31, 2022 | -37.34M |
| September 30, 2022 | -28.10M |
| June 30, 2022 | -30.70M |
| March 31, 2022 | -33.35M |
| December 31, 2021 | -34.73M |
| September 30, 2021 | -73.22M |
| June 30, 2021 | -73.35M |
| March 31, 2021 | -70.26M |
| December 31, 2020 | -79.57M |
| September 30, 2020 | -42.82M |
| June 30, 2020 | -38.19M |
| March 31, 2020 | -34.19M |
| December 31, 2019 | -25.35M |
| September 30, 2019 | -20.97M |
| June 30, 2019 | -22.67M |
| March 31, 2019 | -24.14M |
| November 30, 2018 | -21.24M |
| August 31, 2018 | -17.64M |
| May 31, 2018 | -12.10M |
| February 28, 2018 | -7.598M |
| Date | Value |
|---|---|
| November 30, 2017 | -4.808M |
| August 31, 2017 | -5.057M |
| May 31, 2017 | -4.577M |
| February 28, 2017 | -3.367M |
| November 30, 2016 | -5.208M |
| August 31, 2016 | -5.371M |
| May 31, 2016 | -5.301M |
| February 29, 2016 | -4.736M |
| November 30, 2015 | -3.688M |
| August 31, 2015 | -2.874M |
| May 31, 2015 | -1.770M |
| February 28, 2015 | -1.581M |
| November 30, 2014 | -1.434M |
| August 31, 2014 | -1.568M |
| May 31, 2014 | -1.942M |
| February 28, 2014 | -2.048M |
| November 30, 2013 | -1.997M |
| August 31, 2013 | -1.835M |
| May 31, 2013 | -1.595M |
| February 28, 2013 | -1.392M |
| November 30, 2012 | -1.061M |
| August 31, 2012 | -0.7625M |
| May 31, 2012 | -0.4504M |
| February 29, 2012 | -0.1251M |
| November 30, 2011 | -0.0002M |
Free Cash Flow Range, Past 5 Years
-79.57M
Minimum
Dec 2020
-13.05M
Maximum
Mar 2024
-39.42M
Average
-34.46M
Median
Free Cash Flow Benchmarks
| Altimmune Inc | -72.76M |
| Verastem Inc | -94.50M |
| Oragenics Inc | -8.246M |
| Actinium Pharmaceuticals Inc | -39.72M |
| Dare Bioscience Inc | -30.19M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.441M |
| Cash from Investing (Quarterly) | -0.068M |
| Cash from Financing (Quarterly) | 3.614M |
| Free Cash Flow Per Share (Quarterly) | -0.14 |
| Free Cash Flow to Equity (Quarterly) | -8.36M |
| Free Cash Flow to Firm (Quarterly) | -3.841M |
| Free Cash Flow Yield | -75.42% |